Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Pharma
Novartis' Pluvicto slows progression in earlier prostate cancer
Novartis also reported an early positive trend in overall survival, although that data point remained immature.
Angus Liuu
Oct 19, 2025 10:30am
ESMO: Eli Lilly looks to drive Verzenio adoption with survival win
Oct 17, 2025 8:00am
Novartis advances IgAN efforts with another phase 3 win
Oct 16, 2025 9:30am
Novartis survey explores women's feelings about breast health
Oct 7, 2025 3:30pm
Novartis' BTK inhibitor wins FDA approval in chronic hives
Sep 30, 2025 6:40pm
Novartis earns FDA ire for 'misleading' Fabhalta ad imagery
Sep 30, 2025 11:12am
